Posted on

3 Top Penny Stocks To Monitor This Moment

232 Views
0 Total shares
penny stocks

Among the most researched stocks out there, penny stocks are some of the most closely watched. For the most part, traders eyeball these stocks while looking for catalysts that could potentially inject momentum into them. This could be a simple thing like a press release or even tweet with the right information.

Timing is one of the most important things, if not the most, when researching penny stocks. News can come out at any time of day, but more times than not it will be released in the early AM. It’s key that you pick apart the news and find the crucial/vital information that will influence the market that day, or later down the road.

Read More: 3 Top Clean Energy Penny Stocks For 2020

Knowing these few thoughts, here are a few penny stocks to keep a close watch on Wednesday. Could they become the biggest penny stock gainers of the day? Potentially, but you’ll need to monitor them immediately.

Your Top Penny Stock To Watch No. 1: Nano Dimension Ltd.

Nano Dimension (Nasdaq: NNDM) is a provider of intelligent machines for the fabrication of Additively Manufactured Electronics (AME).

High fidelity active electronic and electromechanical subassemblies are integral enablers of autonomous intelligent drones, cars, satellites, smartphones, and in vivo medical devices.

They necessitate iterative development, IP safety, fast time-to-market and device performance gains, thereby mandating AME for in-house, rapid prototyping and production.

Sensor solutions provider HENSOLDT together with the leading Additively Manufactured Electronics (AME) / Printed Electronics (PE) provider, Nano Dimension, has achieved a major breakthrough on its way to utilizing 3D printing in the development process of high-performance electronics components.

Utilizing a newly developed dielectric polymer ink and conductive ink from Nano Dimension, HENSOLDT succeeded in assembling the world-wide first 10-layer printed circuit board (PCB) which carries high-performance electronic structures soldered to both outer sides.

Until now, 3D printed boards could not bear the soldering process necessary for two-sided population of components.

Your Top Penny Stock To Watch No. 2: Safe-T Group Ltd.

Safe-T Group Ltd. (Nasdaq: SFET) is a provider of Zero Trust Access solutions which mitigate attacks on enterprises’ business-critical services and sensitive data, while ensuring uninterrupted business continuity.

Safe-T’s cloud and on-premises solutions ensure that an organization’s access use cases, whether into the organization or from the organization out to the internet, are secured according to the “validate first, access later” philosophy of Zero Trust.

This means that no one is trusted by default from inside or outside the network, and verification is required from everyone trying to gain access to resources on the network or in the cloud.

Safe-T® Group Ltd. announced that its wholly owned subsidiary, NetNut Ltd., has expanded into a new market with the signing of agreements with three leading companies operating in the consumer VPN sector.

The agreements will allow these VPN companies to use NetNut’s unique global network and provide their end users with a faster, stable, and better secured connections over the internet to various websites.

The Coronavirus pandemic (COVID-19) has created unprecedented working challenges for companies as well as for private users across the globe, and remote access tools are helping them meet these challenges. NetNut’s infrastructure improves the remote connectivity, thus providing a better user experience.

Your Top Penny Stock To Watch No. 3: Surface Oncology

Surface Oncology (Nasdaq: SURF) is an immuno-oncology company developing next-generation antibody therapies focused on the tumor microenvironment.

Its pipeline includes two wholly-owned lead programs targeting CD39 (SRF617) and IL-27 (SRF388), a clinical-stage collaboration with Novartis targeting CD73 (NZV930), and two preclinical programs, each focused primarily on activating natural killer cells (via targeting CD112R) or depleting regulatory T cells (via targeting CCR8).

Surface’s novel cancer immunotherapies are designed to achieve a clinically meaningful and sustained anti-tumor response and may be used alone or in combination with other therapies.

Surface Oncology announced that it has raised gross proceeds of approximately $28.9 million through its At-the-Market, or ATM, facility with participation based on interest received from EcoR1 Capital LLC, Venrock Healthcare Capital Partners, BVF Partners L.P., and RS Investments, a Victory Capital investment franchise.

Surface Oncology sold approximately 10.9 million shares of its common stock at a purchase price of $2.66, the market price at the time of the sale.  This transaction exhausts the balance on the $30 million ATM facility. JonesTrading Institutional Services LLC is acting as the sales agent for the ATM facility.

Daily updates